ArticleCells2025
Structural Alterations of Human Erythrocytes Induced by Minocycline.
Article in Cells, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The non-antibacterial effects of the tetracycline antibiotic minocycline on human erythrocytes are currently under investigation. Our data indicate alterations in the surface structure of erythrocytes; the antibiotic promotes the redistribution of cellular transformational forms during preliminary in vitro incubation (1 h and 24 h) with the modifier. The degree of surface relief changes increases over time, leading to the formation of erythrocytes displaying outgrowths and ridges, spherulation, and "deflated ball"-shaped cells (after 1 day). These alterations are largely reversible, as washing the erythrocyte suspensions with a 1% bovine serum albumin solution reduces the number of echinocytes and irreversibly transformed spherocytes with spikes. Spectrophotometric analysis has shown that minocycline stabilizes the spatial organization of hemoprotein molecules, as it does not lead to increased methemoglobin formation in the samples over time. The antibiotic appears to bind primarily to amino acid residues within heme pockets, as confirmed by molecular docking. Our findings suggest a potential risk of reduced oxygen transport function in red blood cells when taking this antibiotic, highlighting the need to consider potential erythrocyte-related side effects during long-term minocycline therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.